In a double-blind trial, 0· 5% podofilox (podophyllotoxin) or placebo was applied by patients
to their own genital warts in up to four treatment cycles. At some time during the study, 25 of …

Abstract Patient-applied formulations of 0.5% podofilox (podophyllotoxin) were evaluated for
the treatment of external genital warts in a double-blind, placebo-controlled study …

Abstract purpose: For the patient-administered treatment of anogenital warts, 0.5% podofilox
(podophyllotoxin), one of the active compounds of podophyllin, has been shown to be more …

OBJECTIVE--To evaluate the efficacy-safety ratio of a new topical podophyllotoxin cream
0.5% compared with podophyllotoxin solution 0.5%(Condyline) in male patients with genital …

Abstract purpose: Genital warts are a highly prevalent and chronic sexually transmitted
disease for which there is no completely satisfactory therapy. Conventional ablative therapy …

Sixty women with genital warts were randomly allocated to treatment with either weekly
application of 20% podophyllin solution or self-treatment with 0.5% podophyllotoxin cream …

The purpose of this study was to determine the efficacy and safety of 0.5% podofilox solution
(Condylox) for the treatment of genital warts in women. Thirty-seven women with anogenital …

The increasing incidence of genital warts has led to more public awareness of this infection
and its possible sequelae. Currently available treatment remains unsatisfactory, and there is …

OBJECTIVE--To evaluate the clinical efficacy of a 0.15% and a 0.3% cream formulation of
podophyllotoxin in comparison with the 0.5% solution in the treatment of condylomata …

Objectives: To evaluate the efficacy and cost effectiveness of self applied podophyllotoxin
0.5% solution and podophyllotoxin 0.15% cream, compared to clinic applied 25 …